The DOI matches its Crossref record; 129 of the 129 references it cites were found in a registry or an index.
Agomelatine, the first melatonergic antidepressant: discovery, characterization and development
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stress, Depression, and Neuroplasticity: A Convergence of Mechanisms
Pittenger, C., & Duman, R. S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301574 · Cited by 1,795
Cognitive deficits in depression: Possible implications for functional neuropathology
Austin, M.-P., Mitchell, P., & Goodwin, G. M. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.178.3.200 · Cited by 1,154
Walker, M. P., & Stickgold, R. (2006) · Annual Review of Psychology · doi:10.1146/annurev.psych.56.091103.070307 · Cited by 1,075 · cited 1×
“Second, agomelatine possesses several complementary mechanisms that potentially favour cognitive performance: enhancement of dopaminergic and adrenergic input to the frontal cortex; increased hippocampal neurogenesis; moderation of stress-induced HPA overactivity; reinforced slow-wave sleep without loss of rapid eye m…”
BackgroundRegulation of serotonin-2C receptor G-protein coupling by RNA editing
Burns, C. M., Chu, H., Rueter, S. M., Hutchinson, L. K., Canton, H., Sanders-Bush, E., & Emeson, R. B. (1997) · Nature · doi:10.1038/387303a0 · Cited by 1,010
Melatonin: Nature’s most versatile biological signal?
Pandi‐Perumal, S. R., Srinivasan, V., Maestroni, G. J. M., Cardinali, D. P., Poeggeler, B., & Hardeland, R. (2006) · The FEBS Journal · doi:10.1111/j.1742-4658.2006.05322.x · Cited by 875
Cognitive therapy versus medication for depression: treatment outcomes and neural mechanisms
DeRubeis, R. J., Siegle, G. J., & Hollon, S. D. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2345 · Cited by 690
Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission
Alex, K. D., & Pehek, E. A. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.08.004 · Cited by 658
Circadian rhythm disturbances in depression
Germain, A., & Kupfer, D. J. (2008) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.964 · Cited by 644
Melatonin receptors: Localization, molecular pharmacology and physiological significance
Morgan, P. J., Barrett, P., Howell, H. E., & Helliwell, R. (1994) · Neurochemistry International · doi:10.1016/0197-0186(94)90100-7 · Cited by 623
Treatment-Emergent Sexual Dysfunction Related to Antidepressants: A Meta-Analysis
Serretti, A., & Chiesa, A. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181a5233f · Cited by 583
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Self-citationHuman pineal physiology and functional significance of melatonin
Macchi, M. M., & Bruce, J. N. (2004) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2004.08.001 · Cited by 547
Preskorn, S. H., Baker, B., Kolluri, S., Menniti, F. S., Krams, M., & Landen, J. W. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31818a6cea · Cited by 518
Millan, M. J., Gobert, A., Lejeune, F., Dekeyne, A., Newman-Tancredi, A., Pasteau, V., Rivet, J.-M., & Cussac, D. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.051797 · Cited by 516
Self-citationBerg, K. A., Maayani, S., Goldfarb, J., Scaramellini, C., Leff, P., & Clarke, W. P. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.1.94 · Cited by 510
Manji, H. K., Quiroz, J. A., Sporn, J., Payne, J. L., Denicoff, K., A. Gray, N., Zarate, C. A., & Charney, D. S. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00117-3 · Cited by 505
Dopamine and serotonin: influences on male sexual behavior
Hull, E. M., Muschamp, J. W., & Sato, S. (2004) · Physiology & Behavior · doi:10.1016/j.physbeh.2004.08.018 · Cited by 465
Stahl, S. M., Grady, M. M., Moret, C., & Briley, M. (2005) · CNS Spectrums · doi:10.1017/s1092852900019726 · Cited by 458
Melatonin receptors step into the light: cloning and classification of subtypes
Reppart, S. M., Weaver, D. R., & Godson, C. (1996) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(96)10005-5 · Cited by 423
Hypothalamic melatonin receptor sites revealed by autoradiography
Vaněček, J., Pavlík, A., & Illnerová, H. (1987) · Brain Research · doi:10.1016/0006-8993(87)91625-8 · Cited by 401
Souêtre, E., Salvati, E., Belugou, J.-L., Pringuey, D., Candito, M., Krebs, B., Ardisson, J.-L., & Darcourt, G. (1989) · Psychiatry Research · doi:10.1016/0165-1781(89)90207-2 · Cited by 396
Antidepressants and Sleep: A Qualitative Review of the Literature
Wilson, S., & Argyropoulos, S. (2005) · Drugs · doi:10.2165/00003495-200565070-00003 · Cited by 392
Melatonin and the pineal gland: influence on mammalian seasonal and circadian physiology
Arendt, J. (1998) · Reviews of Reproduction · doi:10.1530/revreprod/3.1.13 · Cited by 366
L??o, H., Hale, A., & D??haenen, H. (2002) · International Clinical Psychopharmacology · doi:10.1097/00004850-200209000-00004 · Cited by 361
Ur, E. (1991) · Postgraduate Medical Journal · doi:10.1136/pgmj.67.787.497 · Cited by 345
Goodwin, G. M., Emsley, R., Rembry, S., Rouillon, F., & the Agomelatine Study Group (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04548 · Cited by 340
Signaling at G-protein-coupled serotonin receptors: recent advances and future research directions
MILLAN, M., MARIN, P., BOCKAERT, J., & MANNOURYLACOUR, C. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.06.007 · Cited by 320
Self-citationAgomelatine, a new antidepressant, induces regional changes in hippocampal neurogenesis
Banasr, M., Soumier, A., Hery, M., Mocaër, E., & Daszuta, A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.11.025 · Cited by 318
Papakostas, G. I., Thase, M. E., Fava, M., Nelson, J. C., & Shelton, R. C. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.03.027 · Cited by 308 · cited 1×
“Selective serotonin reuptake inhibitors (SSRIs), noradrenaline reuptake inhibitors (NARIs) and serotonin/noradrenaline reuptake inhibitors (SNRIs) possess improved safety margins as well as utility for treating co-morbid anxiety, but offer no real gain in efficacy over their first-generation counterpart”
BackgroundMelatonin receptors and their regulation: biochemical and structural mechanisms
Witt-Enderby, P. A., Bennett, J., Jarzynka, M. J., Firestine, S., & Melan, M. A. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00098-5 · Cited by 302
Placebo-controlled trial of agomelatine in the treatment of major depressive disorder
Kennedy, S. H., & Emsley, R. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.09.002 · Cited by 294
Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new?
Jockers, R., Maurice, P., Boutin, J. A., & Delagrange, P. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.184 · Cited by 293
Srinivasan, V., Smits, M., Spence, W., Lowe, A. D., Kayumov, L., Pandi-Perumal, S. R., Parry, B., & Cardinali, D. P. (2006) · The World Journal of Biological Psychiatry · doi:10.1080/15622970600571822 · Cited by 292
Chronotherapeutics (light and wake therapy) in affective disorders
WIRZ-JUSTICE, A., BENEDETTI, F., BERGER, M., LAM, R. W., MARTINY, K., TERMAN, M., & WU, J. C. (2005) · Psychological Medicine · doi:10.1017/s003329170500437x · Cited by 291
Musazzi, L., Milanese, M., Farisello, P., Zappettini, S., Tardito, D., Barbiero, V. S., Bonifacino, T., Mallei, A., Baldelli, P., Racagni, G., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008566 · Cited by 289
Millan, M. J. (2005) · Therapies · doi:10.2515/therapie:2005065 · Cited by 283
Self-citationAdult Hippocampal Neurogenesis, Synaptic Plasticity and Memory: Facts and Hypotheses
Bruel-Jungerman, E., Rampon, C., & Laroche, S. (2007) · Reviews in the Neurosciences · doi:10.1515/revneuro.2007.18.2.93 · Cited by 282
Effect of Agomelatine in the Chronic Mild Stress Model of Depression in the Rat
Papp, M., Gruca, P., Boyer, P.-A., & Mocaër, E. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300091 · Cited by 268
Self-citationCastro-Costa, E., Dewey, M., Stewart, R., Banerjee, S., Huppert, F., Mendonca-Lima, C., Bula, C., Reisches, F., Wancata, J., Ritchie, K., et al. (2007) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.036772 · Cited by 260
Kasper, S., Hajak, G., Wulff, K., Hoogendijk, W. J. G., Montejo, A. L., Smeraldi, E., Rybakowski, J. K., Quera-Salva, M.-A., Wirz-Justice, A. M., Picarel-Blanchot, F., et al. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05347blu · Cited by 257
Kramer, M. S., Winokur, A., Kelsey, J., Preskorn, S. H., Rothschild, A. J., Snavely, D., Ghosh, K., Ball, W. A., Reines, S. A., Munjack, D., et al. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300260 · Cited by 256
Pierre Olié, J., & Kasper, S. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707007766 · Cited by 256
Binneman, B., Feltner, D., Kolluri, S., Shi, Y., Qiu, R., & Stiger, T. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07071199 · Cited by 254 · cited 1×
“Unfortunately, clinical trials have been disappointin”
Circadian misalignment in major depressive disorder
Emens, J., Lewy, A., Kinzie, J. M., Arntz, D., & Rough, J. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2009.04.009 · Cited by 253
Morilak, D. A., & Frazer, A. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004080 · Cited by 252
New selective ligands of human cloned melatonin MT1 and MT2 receptors
Audinot, V., Mailliet, F., Lahaye-Brasseur, C., Bonnaud, A., Le Gall, A., Amossé, C., Dromaint, S., Rodriguez, M., Nagel, N., Galizzi, J.-P., et al. (2003) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-003-0751-2 · Cited by 248
Self-citationMillan, M. J., Brocco, M., Gobert, A., & Dekeyne, A. (2005) · Psychopharmacology · doi:10.1007/s00213-004-1962-z · Cited by 248
Self-citationInfluence of sleep-wake and circadian rhythm disturbances in psychiatric disorders.
Boivin, D. B. (2000) · PubMed · Cited by 248
Serotonin 5‐HT2C receptors regulate anxiety‐like behavior
Heisler, L. K., Zhou, L., Bajwa, P., Hsu, J., & Tecott, L. H. (2007) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2007.00316.x · Cited by 242
Novel naphthalenic ligands with high affinity for the melatonin receptor
Yous, S., Andrieux, J., Howell, H. E., Morgan, P. J., Renard, P., Pfeiffer, B., Lesieur, D., & Guardiola-Lemaitre, B. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00086a018 · Cited by 234
Self-citationBourin, M., Mocaër, E., & Porsolt, R. (2004) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0414 · Cited by 226
Self-citationNovel Drugs and Therapeutic Targets for Severe Mood Disorders
Mathew, S. J., Manji, H. K., & Charney, D. S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301652 · Cited by 223
Specific Binding of Melatonin in Bovine Brain*
CARDINALI, D. P., VACAS, M. I., & BOYER, E. E. (1979) · Endocrinology · doi:10.1210/endo-105-2-437 · Cited by 217
Lemoine, P., & Guilleminault, C. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n1112 · Cited by 217
Kennedy, S. H., Rizvi, S., Fulton, K., & Rasmussen, J. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318172b48c · Cited by 212
Montgomery, S. A., Kennedy, S. H., Burrows, G. D., Lejoyeux, M., & Hindmarch, I. (2004) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000137184.64610.c8 · Cited by 196
Millan, M. J. (2009) · Neurotherapeutics · doi:10.1016/j.nurt.2008.10.039 · Cited by 196
Self-citationKrauchi, K., Cajochen, C., Mori, D., Graw, P., & Wirz-Justice, A. (1997) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1997.272.4.r1178 · Cited by 196
Stein, D. J., Ahokas, A. A., & de Bodinat, C. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318184ff5b · Cited by 174
Self-citationContributions of 5-HT2C receptors to multiple actions of central serotonin systems
Giorgetti, M., & Tecott, L. H. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.01.036 · Cited by 173
Soumier, A., Banasr, M., Lortet, S., Masmejean, F., Bernard, N., Kerkerian-Le-Goff, L., Gabriel, C., Millan, M. J., Mocaer, E., & Daszuta, A. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.72 · Cited by 171
Self-citationMajor depressive disorder, sleep EEG and agomelatine: an open-label study
Salva, M.-A. Q., Vanier, B., Laredo, J., Hartley, S., Chapotot, F., Moulin, C., Lofaso, F., & Guilleminault, C. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707007754 · Cited by 170
Leproult, R., Van Onderbergen, A., L’Hermite‐Balériaux, M., Van Cauter, E., & Copinschi, G. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02341.x · Cited by 167
Circadian rhythms and the pharmacology of affective illness
Duncan, W. C. (1996) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(96)00092-7 · Cited by 167
Which antidepressants have demonstrated superior efficacy? A review of the evidence
Montgomery, S. A., Baldwin, D. S., Blier, P., Fineberg, N. A., Kasper, S., Lader, M., Lam, R. W., Lépine, J.-P., Möller, H.-J., Nutt, D. J., et al. (2007) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3282eff7e0 · Cited by 165
The Diagnosis, Symptomatology, and Epidemiology of Seasonal Affective Disorder
Magnusson, A., & Partonen, T. (2005) · CNS Spectrums · doi:10.1017/s1092852900019593 · Cited by 164
Management of Patients With Treatment-Resistant Depression
Thase, M. E. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.0308e08 · Cited by 158
Groth, E. (1999) · Nature Biotechnology · doi:10.1038/14992 · Cited by 156
Pathophysiology of depression: Role of sleep and the melatonergic system
Srinivasan, V., Pandi-Perumal, S. R., Trakht, I., Spence, D. W., Hardeland, R., Pöeggeler, B., & Cardinali, D. P. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2007.11.020 · Cited by 156
Luo, A. H., & Aston‐Jones, G. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06606.x · Cited by 156
Agomelatine in the Treatment of Major Depressive Disorder: Potential for Clinical Effectiveness
Kennedy, S. H., & Rizvi, S. J. (2010) · CNS Drugs · doi:10.2165/11534420-000000000-00000 · Cited by 153
Discontinuation symptoms in depression and anxiety disorders
Baldwin, D. S., Montgomery, S. A., Nil, R., & Lader, M. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705006358 · Cited by 140
Gerdin, M. J., Masana, M. I., Rivera-Bermudez, M. A., Hudson, R. L., Earnest, D. J., Gillette, M. U., & Dubocovich, M. L. (2004) · The FASEB Journal · doi:10.1096/fj.03-1339com · Cited by 137
Acknowledgement of Reviewers for Volume 16
Papp, M., Litwa, E., Gruca, P., & Mocaër, E. (2005) · Journal of Child Custody · doi:10.1080/15379418.2019.1703621 · Cited by 134
Self-citationDekeyne, A., la Cour, C. M., Gobert, A., Brocco, M., Lejeune, F., Serres, F., Sharp, T., Daszuta, A., Soumier, A., Papp, M., et al. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1177-9 · Cited by 131
Self-citationSuccessful use of S20098 and melatonin in an animal model of delayed sleep-phase syndrome (DSPS)
Armstrong, S. M., McNulty, O. M., Lemaître, B. J., & Redman, J. R. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90315-k · Cited by 129
Antidepressant-like effects of agomelatine (S 20098) in the learned helplessness model
Bertaina‐Anglade, V., Rochelle, C. D. L., Boyer, P., & Mocaër, E. (2006) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3280116e5c · Cited by 128
Self-citationWeil, Z. M., Hotchkiss, A. K., Gatien, M. L., Pieke-Dahl, S., & Nelson, R. J. (2005) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2005.09.016 · Cited by 125
Kasper, S. F., & Hamon, M. (2009) · The World Journal of Biological Psychiatry · doi:10.1080/15622970902717024 · Cited by 123
Tachykinin Receptors as Therapeutic Targets in Stress-Related Disorders
Ebner, K., Sartori, S. B., & Singewald, N. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788168074 · Cited by 121
Weight gain in the treatment of mood disorders.
Aronne, L. J., & Segal, K. R. (2003) · PubMed · Cited by 120
Pitrosky, B., Kirsch, R., Malan, A., Mocaër, E., & Pévet, P. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.277.3.r812 · Cited by 119
Self-citationAgomelatine in the treatment of seasonal affective disorder
Pjrek, E., Winkler, D., Konstantinidis, A., Willeit, M., Praschak-Rieder, N., & Kasper, S. F. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0645-3 · Cited by 117
Papakostas, G. I., Stahl, S. M., Krishen, A., Seifert, C. A., Tucker, V. L., Goodale, E. P., & D, M. F. M. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0812 · Cited by 117
Melatonin analogues as agonists and antagonists in the circadian system and other brain areas
Ying, S.-W., Rusak, B., Delagrange, P., Mocaër, E., Renard, P., & Guardiola-Lemaître, B. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00684-2 · Cited by 114
Self-citationRedman, J., Brown, M., Lemaître, B. J., Delagrange, P., & Armstrong, S. M. (1995) · Psychopharmacology · doi:10.1007/bf02245938 · Cited by 113
Current status of inverse agonism at serotonin2A (5-HT2A) and 5-HT2C receptors
Aloyo, V. J., Berg, K. A., Spampinato, U., Clarke, W. P., & Harvey, J. A. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.10.010 · Cited by 112
Sartorius, N., Baghai, T. C., Baldwin, D. S., Barrett, B. M., Brand, U., Fleischhacker, W., Goodwin, G. M., Grunze, H., Knapp, M. R. J., Leonard, B. E., et al. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008255 · Cited by 106
Martinet, L., Lemaître, B. J., & Mocaër, E. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02221-x · Cited by 104
Self-citationAntidepressant action of agomelatine (S 20098) in a transgenic mouse model
Barden, N., Shink, É., Labbé, M., Vacher, R., Rochford, J. M., & Mocaër, E. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.04.032 · Cited by 102
Self-citationChanrion, B., la Cour, C. M., Gavarini, S., Seimandi, M., Vincent, L., Pujol, J. F., Bockaert, J., Marin, P., & Millan, M. J. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.041574 · Cited by 102
Self-citationLane, H., Lee, C.-C., Chang, Y., Lu, C. ‐., Huang, C.-H., & Chang, W. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004389 · Cited by 101
Circadian rhythms and memory: not so simple as cogs and gears
Eckel‐Mahan, K. L., & Storm, D. R. (2009) · EMBO Reports · doi:10.1038/embor.2009.123 · Cited by 100
Montejo, A. L., Prieto, N., Terleira, A. I., Matias, J., Alonso, S., Paniagua, G., Naval, S., Parra, D., Gabriel, C., Mocaër, E., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108096507 · Cited by 100
Self-citationSerotonin 5-HT2c agonists mimic the effect of light pulses on circadian rhythms
Kennaway, D. J., & Moyer, R. W. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00746-x · Cited by 97
Modulation of voltage-dependent Ca2+ conductance by changing Cl- concentration in rat lactotrophs
García, L., Fahmi, M., Prevarskaya, N. B., DUFY, B., & Sartor, P. (1997) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1997.272.4.c1178 · Cited by 91
Cajochen, C., Kräuchi, K., Mori, D., Graw, P., & Wirz‐Justice, A. (1997) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1997.272.4.r1189 · Cited by 88
Reeth, O. V., Weibel, L., Olivares, E., Maccari, S., Mocaër, E., & Turek, F. W. (2001) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2001.280.5.r1582 · Cited by 86
Self-citationKehne, J. H. (2007) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152707780619344 · Cited by 82
Comparative aspects of the pineal/melatonin system of poikilothermic vertebrates
Filadelfi, A. M. C., & Castrucci, A. M. D. L. (1996) · Journal of Pineal Research · doi:10.1111/j.1600-079x.1996.tb00256.x · Cited by 81
Barassin, S., Raison, S., Saboureau, M., Bienvenu, C., Maître, M., Malan, A., & Pévet, P. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.01928.x · Cited by 76
Redman, J. R., & Francis, A. J. P. (1998) · Journal of Biological Rhythms · doi:10.1177/074873098128999907 · Cited by 74
Comparative effects of a melatonin agonist on the circadian system in mice and Syrian hamsters
Reeth, O. V., Olivares, E., Zhang, Y., Zee, P. C., Mocaër, E., Defrance, R., & Turek, F. W. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00382-x · Cited by 71
Self-citationConboy, L., Tanrıkut, C., Zoladz, P. R., Campbell, A. M., Park, C. R., Gabriel, C., Mocaër, E., Sandi, C., & Diamond, D. M. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009255 · Cited by 71
Self-citationGerdin, M. J., Masana, M. I., Ren, D., Miller, R. J., & Dubocovich, M. L. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.044990 · Cited by 70
New light on the serotonergic paradox in the rat circadian system
Cuesta, M., Clesse, D., Pévet, P., & Challet, E. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06128.x · Cited by 67
Effects of melatonin receptor ligands on swim test immobility
Overstreet, D. H., Puciłowski, O., Retton, M.-C., Delagrange, P., & Lemaître, B. J. (1998) · Neuroreport · doi:10.1097/00001756-199801260-00014 · Cited by 67
Managing the Patient with Co-Morbid Depression and an Anxiety Disorder
Schoevers, R. A., Van, H. L., Koppelmans, V., Kool, S., & Dekker, J. (2008) · Drugs · doi:10.2165/00003495-200868120-00002 · Cited by 66
Tuma, J., Strubbe, J. H., Mocaër, E., & Koolhaas, J. M. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.02.004 · Cited by 60
Self-citationAcute low doses of melatonin restore full sexual activity in impotent male rats
Drago, F., & Busă, L. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02715-3 · Cited by 57
Melatonin protects against the effects of chronic stress on sexual behaviour in male rats
Brotto, L. A., Gorzalka, B. B., & LaMarre, A. K. (2001) · Neuroreport · doi:10.1097/00001756-200111160-00018 · Cited by 56
IJNP Editorial Board: Meeting new challenges
Lerer, B. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145706007498 · Cited by 54
Leuchter, A. F., Morgan, M. L., Cook, I. A., Dunkin, J. J., Abrams, M., & Witte, E. A. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1919-2 · Cited by 50
Grassi-Zucconi, G., Semprevivo, M., Mocaër, E., Kristensson, K., & Bentivoglio, M. (1996) · Brain Research Bulletin · doi:10.1016/0361-9230(95)02032-2 · Cited by 50
Self-citationThe interaction between the internal clock and antidepressant efficacy
Racagni, G., Riva, M. A., & Popoli, M. (2007) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000277957.75852.c7 · Cited by 48
Descamps, A., Rousset, C., Millan, M. J., Spedding, M., Delagrange, P., & Cespuglio, R. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1519-2 · Cited by 48
Self-citationEitan, R., & Lerer, B. (2006) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2006.8.2/reitan · Cited by 43
Hoffen, G. C. K., Mirmiran, M., Bos, N. P. A., Witting, W., Delagrange, P., & Lemaître, B. J. (1993) · Neurobiology of Aging · doi:10.1016/0197-4580(93)90040-i · Cited by 42
Ying, S., Rusak, B., & Mocaër, E. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01443-x · Cited by 40
Self-citationResynchronisation of a diurnal rodent circadian clock accelerated by a melatonin agonist
Reeth, O. V., Olivares, E., Turek, F. W., Granjon, L., & Mocaër, E. (1998) · Neuroreport · doi:10.1097/00001756-199806010-00043 · Cited by 38
Self-citationGannon, R. L., & Millan, M. J. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.04.059 · Cited by 37
Self-citationWong, E. H. F., Nikam, S. S., & Shahid, M. (2008) · PubMed · Cited by 34
Activation of 5-HT2C receptors acutely induces Per1 gene expression in the rat SCN in vitro
Varcoe, T. J., & Kennaway, D. J. (2008) · Brain Research · doi:10.1016/j.brainres.2008.02.091 · Cited by 34
Goodwin, G. M., Rouillon, F., & Emsley, R. A. (2008) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(08)70471-1 · Cited by 13
Improving antidepressant drugs: update on recently patented compounds
Rozas, I. (2009) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543770902932934 · Cited by 11
Corbach‐Söhle, S., Schmelting, B., Fuchs, E., & Mocaër, E. (2007) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(07)70534-5 · Cited by 9
Self-citationAugmentation in treatment-resistant depression
McIntyre, J., & Moral, M. A. (2006) · Drugs of the Future · doi:10.1358/dof.2006.031.12.1049172 · Cited by 7
Linnik, I. G., McKie, S., Stark, J., et al. (2009) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(09)70374-8 · Cited by 5
[New naphthalenic ligands of melatoninergic receptors].
Adam, G., Lemaître, B. J., Yous, S., et al. (1992) · PubMed · Cited by 2
Research works printed but not linked: 4
- Guardiola-Lemaitre, B. & Delagrange, P. Melatonin analogues: from pharmacology to clinical application. Eur. J. Med. Chem. 30, S643–S651 (1995). · doi:10.1016/s0223-5234(23)00157-5
- Corbach-Söhle, S. et al. Effects of agomelatine and S32006, a selective 5-HT2C receptor antagonist, in chronically-stressed tree shrews. Eur. Neuropsychopharmacol. 18, S348 (2008). · doi:10.1016/s0924-977x(08)70488-7
- Berk, M. & Dodd, S. Antidepressants and the placebo response. Hum. Psychopharmacol. Clin. Exp. 20, 305–307 (2005). · DOI
- Papp, M., Litwa, E., Gruca, P. & Mocaër, E. Anxiolytic-like activity of agomelatine and melatonin in three animal models of anxiety. Behav. Pharmacol. 17, 9–18 (2006).
Cited by
MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective
Liu, J., Clough, S. J., Hutchinson, A. J., Adamah-Biassi, E. B., Popovska-Gorevski, M., & Dubocovich, M. L. (2016) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124742 · Cited by 630
Update on melatonin receptors: IUPHAR Review 20
Jockers, R., Delagrange, P., Dubocovich, M. L., Markus, R. P., Renault, N., Tosini, G., Cecon, E., & Zlotos, D. P. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13536 · Cited by 422
Melatonin and its analogs in insomnia and depression
Cardinali, D. P., Srinivasan, V., Brzezinski, A., & Brown, G. M. (2012) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00962.x · Cited by 353
Novel melatonin-based therapies: potential advances in the treatment of major depression
Hickie, I. B., & Rogers, N. L. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60095-0 · Cited by 334
Virtual discovery of melatonin receptor ligands to modulate circadian rhythms
Stein, R. M., Kang, H. J., McCorvy, J. D., Glatfelter, G. C., Jones, A. J., Che, T., Slocum, S., Huang, X.-P., Savych, O., Moroz, Y. S., et al. (2020) · Nature · doi:10.1038/s41586-020-2027-0 · Cited by 298
Metadata
- Authors
- de Bodinat, C., Guardiola-Lemaitre, B., Mocaër, E., Renard, P., Muñoz, C., & Millan, M. J.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2010-06-25
- Volume
- 9
- Issue
- 8
- Pages
- 628-642
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2161731199
- Cited by
- 593
- References
- 129
- FWCI
- 5.87
- Type
- journal article
- Language
- en
- Update notices
- erratum (2010-09-01)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.